Daratumumab for refractory warm autoimmune hemolytic anemia

被引:0
作者
Ankur Jain
D. K. Gupta
机构
[1] Vardhman Mahavir Medical College and Safdarjung Hospital,Department of Haematology
来源
Annals of Hematology | 2021年 / 100卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1351 / 1353
页数:2
相关论文
共 56 条
  • [1] Jäger U(2019)Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting Blood Rev 100648 100648-128
  • [2] Barcellini W(2019)Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia Br J Haematol 187 124-3076
  • [3] Broome CM(2001)The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells Cancer Res 61 3071-106
  • [4] Gertz MA(2015)Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma Haematologica. 100 100-2553
  • [5] Hill A(2018)Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation Blood Adv 2 2550-undefined
  • [6] Hill QA(undefined)undefined undefined undefined undefined-undefined
  • [7] Jilma B(undefined)undefined undefined undefined undefined-undefined
  • [8] Kuter DJ(undefined)undefined undefined undefined undefined-undefined
  • [9] Michel M(undefined)undefined undefined undefined undefined-undefined
  • [10] Montillo M(undefined)undefined undefined undefined undefined-undefined